KURA ONCOLOGY, INC. Adjustments to Additional Paid in Capital, Warrant Issued
KURA ONCOLOGY, INC. (KURA) reported Adjustments to Additional Paid in Capital, Warrant Issued of $32.66 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-11-02.
Financial Statements › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-02-28
- KURA ONCOLOGY, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-06-30 was $32.66M.
- KURA ONCOLOGY, INC. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $294.00K.
- KURA ONCOLOGY, INC. adjustments to additional paid in capital, warrant issued for fiscal 2016 was $172.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2023-06-30 | $32.66M 10-Q · filed 2023-11-02 | |
| 2022-12-31 | $294.00K 10-K · filed 2025-02-28 | |
| 2016-12-31 | $172.00K 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |